Biogen Opicinumab(Anti-LINGO-1) Fails Phase 2 Study of in MS

A board to discuss future MS therapies in early stage (Phase I or II) trials.
Post Reply
User avatar
ton
Family Member
Posts: 78
Joined: Thu May 27, 2010 2:00 pm

Biogen Opicinumab(Anti-LINGO-1) Fails Phase 2 Study of in MS

Post by ton »

:sad: Biogen Reports Top-Line Results from Phase 2 Study of Opicinumab (Anti-LINGO-1) in Multiple Sclerosis

http://media.biogen.com/press-release/i ... anti-lingo
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Drug Pipeline”